FDA NDI Draft Is A Push For Tighter Supplement Regulation – Stakeholders
This article was originally published in The Tan Sheet
FDA proposed “a pretty crazy” NDI notification draft guidance, says attorney Wes Siegner, because “they think everything is an NDI.” Other stakeholders acknowledge FDA wants tighter regulation of the industry, but say writing and imposing rules for supplement manufacturing is a two-way street.
You may also be interested in...
FDA adds acetaminophen warnings; CHPA suggests 4-aminophenol standard; OTC HSA bill in House; supplement registration bill reintroduced; FSMA user fees still on hold; more scrutiny of energy drinks; and Public Citizen pans OTC Oxytrol.
Consent decrees allow time for a firm to make changes with the goal of re-opening, but not without costly updates to systems and equipment and retaining a consultant and attorneys, food and drug attorney Tony Young says.
Requirements that benefit dietary supplement manufacturing and that gained Sen. John McCain's support after he initially proposed legislation considered a threat to the industry are part of the food safety reform bill pending in the Senate.